Organization · Venture Capital
Corundum
Corundum is a global convergence investment group founded in 2014, focusing on neuroscience and systems biology. It operates through multiple innovation hubs to foster collaboration among researchers and investors.
Overview
What Corundum does
What Corundum is
Corundum is a global convergence investment group founded in 2014, focusing on neuroscience and systems biology. It operates through multiple innovation hubs to foster collaboration among researchers and investors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Corundum elsewhere
Open the official website or a supported primary organization account.
Capability profile
Corundum as a funder
Investment thesis
Corundum focuses on convergence across science, technology, and business, particularly in neuroscience and systems biology, to foster life-changing discoveries.
Focus narrative
Corundum invests in and supports research and development in key areas such as neuroscience and systems biology. Through its innovation hubs, Corundum engages in venture investment, consulting services, sponsored research, and venture philanthropy, with a commitment to advancing healthcare technology systems and addressing critical health challenges.
Value beyond capital
Corundum adds value to its portfolio companies through strategic support in research and development, access to a network of innovators, and expertise in venture philanthropy. The organization fosters collaboration among its portfolio companies to drive scientific discovery and innovation.
Terms and economics
- Typical check
- $1,000,000–$16,000,000
- Sweet spot
- $8,000,000
Focus and fit
- Stages
- Seed · Series A · Series B
- Regions
- Global · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Corundum's portfolio includes notable companies such as NextSense, which develops wearable EEG earbuds, and Sequential, focusing on microbiome research. Other investments include Appcharge and Pheno.AI, showcasing the organization's commitment to breakthroughs in neuroscience and systems biology.
Common questions
What to know about Corundum
Upseed classifies Corundum under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.